Hernia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

<h4><strong>Market Overview:</strong></h4>

<blockquote>
<p>The 7 major hernia&nbsp;markets are expected to exhibit a CAGR of 2.28% during 2024-2034.</p>
</blockquote>

<table align="center" border="1" cellpadding="1" cellspacing="1" dir="ltr" style="width:100%">
<thead>
<tr>
<th scope="col" style="width:70%">
<div style="text-align:left">Report Attribute&nbsp;</div>
</th>
<th scope="col">
<div style="text-align:left">Key Statistics</div>
</th>
</tr>
</thead>
<tbody>
<tr>
<td>
<div><strong>Base Year</strong></div>
</td>
<td>
<div>2023</div>
</td>
</tr>
<tr>
<td>
<div><strong>Forecast Years</strong></div>
</td>
<td>
<div>2024-2034</div>
</td>
</tr>
<tr>
<td>
<div><strong>Historical Years</strong></div>
</td>
<td>
<div>2018-2023</div>
</td>
</tr>
<tr>
<td><strong>Market Growth Rate 2024-2034</strong></td>
<td>2.28%</td>
</tr>
</tbody>
</table>

<p style="text-align:justify"><br />
The hernia market has been comprehensively analyzed in IMARC&#39;s new report titled <strong>&quot;Hernia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034&quot;.</strong> Hernia refers to a medical condition characterized by the protrusion of an organ or cell through a weak spot or opening in the surrounding muscle or connective tissue. It most commonly occurs in the abdomen but can also affect other areas of the body, such as the groin, diaphragm, umbilical region, etc. The symptoms of this ailment may vary depending on its location and size; however, they usually include a visible bulge, discomfort or pain, an aching or burning sensation, and a feeling of heaviness. In some cases, hernias can progress to an incarcerated or strangulated state, wherein the protruding tissue becomes trapped, leading to a compromised blood supply. The diagnosis of this illness is mainly based on the patient&#39;s medical history and characteristic findings. A healthcare professional will also perform a physical examination to check for visible or palpable signs of the disease, such as a bulge or swelling in the affected area. Various diagnostic procedures, like ultrasounds, computed tomography scans, magnetic resonance imaging, etc., are recommended to visualize internal structures and determine the cause of underlying indications.</p>

<p style="text-align:center"><img alt="Hernia Market" src="https://www.imarcgroup.com/CKEditor/13da0c78-8086-4f92-9bac-90ba85b37275hernia-market.webp" style="height:450px; width:800px" /></p>

<p style="text-align:justify">The increasing cases of congenital syndromes that weaken the abdominal wall or connective tissue, thereby allowing organs or tissues to protrude through, are primarily driving the hernia market. In addition to this, the rising prevalence of various risk factors, like injury, heavy lifting or straining, obesity, etc., which can exert pressure on the stomach muscles, is also creating a positive outlook for the market. Moreover, the widespread adoption of effective medications, including non-steroidal anti-inflammatory drugs, proton pump inhibitors, mild laxatives, etc., to reduce stomach acid production as well as manage symptoms of the ailment, is further bolstering the market growth. Apart from this, the inflating application of physical therapy, since it helps to enhance muscle tone and endurance, thereby contributing to a smoother recovery process in patients, is acting as another significant growth-inducing factor. Additionally, the emerging popularity of robot-assisted surgery to treat the disease on account of its several advantages, such as improved visualization, increased range of motion, shorter hospital stays, etc., is expected to drive the hernia market during the forecast period.&nbsp;</p>

<p style="text-align:justify">IMARC Group&#39;s new report provides an exhaustive analysis of the hernia market in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. This includes treatment practices, in-market, and pipeline drugs, share of individual therapies, market performance across the seven major markets, market performance of key companies and their drugs, etc. The report also provides the current and future patient pool across the seven major markets. According to the report the United States has the largest patient pool for hernia and also represents the largest market for its treatment. Furthermore, the current treatment practice/algorithm, market drivers, challenges, opportunities, reimbursement scenario and unmet medical needs, etc. have also been provided in the report. This report is a must-read for manufacturers, investors, business strategists, researchers, consultants, and all those who have any kind of stake or are planning to foray into the hernia market in any manner.</p>

<p><strong>Time Period of the Study</strong></p>

<ul>
<li>Base Year: 2023</li>
<li>Historical Period: 2018-2023</li>
<li>Market Forecast: 2024-2034<br />
&nbsp;</li>
</ul>

<p><strong>Countries Covered</strong></p>

<ul>
<li>United States</li>
<li>Germany</li>
<li>France</li>
<li>United Kingdom</li>
<li>Italy</li>
<li>Spain</li>
<li>Japan<br />
&nbsp;</li>
</ul>

<p><strong>Analysis Covered Across Each Country</strong></p>

<ul>
<li>Historical, current, and future epidemiology scenario</li>
<li>Historical, current, and future performance of the hernia market</li>
<li>Historical, current, and future performance of various therapeutic categories in the market</li>
<li>Sales of various drugs across the hernia market</li>
<li>Reimbursement scenario in the market</li>
<li>In-market and pipeline drugs</li>
</ul>

<h4><strong>Competitive Landscape:</strong></h4>

<p>This report also provides a detailed analysis of the current hernia marketed drugs and late-stage pipeline drugs.</p>

<p><strong>In-Market Drugs</strong></p>

<ul>
<li>Drug Overview</li>
<li>Mechanism of Action</li>
<li>Regulatory Status</li>
<li>Clinical Trial Results</li>
<li>Drug Uptake and Market Performance&nbsp;&nbsp;&nbsp;&nbsp;<br />
&nbsp;</li>
</ul>

<p><strong>Late-Stage Pipeline Drugs</strong></p>

<ul>
<li>Drug Overview</li>
<li>Mechanism of Action</li>
<li>Regulatory Status</li>
<li>Clinical Trial Results</li>
<li>Drug Uptake and Market Performance</li>
</ul>

<h4><strong>Key Questions Answered in this Report:</strong></h4>

<p><strong>Market Insights</strong></p>

<ul>
<li>How has the hernia market performed so far and how will it perform in the coming years?</li>
<li>What are the markets shares of various therapeutic segments in 2023 and how are they expected to perform till 2034?</li>
<li>What was the country-wise size of the hernia market across the seven major markets in 2023 and what will it look like in 2034?</li>
<li>What is the growth rate of the hernia market across the seven major markets and what will be the expected growth over the next ten years?</li>
<li>What are the key unmet needs in the market?<br />
&nbsp;</li>
</ul>

<p><strong>Epidemiology Insights</strong></p>

<ul>
<li>What is the number of prevalent cases (2018-2034) of hernia across the seven major markets?</li>
<li>What is the number of prevalent cases (2018-2034) of hernia by age across the seven major markets?</li>
<li>What is the number of prevalent cases (2018-2034) of hernia by gender across the seven major markets?</li>
<li>How many patients are diagnosed (2018-2034) with hernia across the seven major markets?</li>
<li>What is the size of the hernia patient pool (2018-2023) across the seven major markets?</li>
<li>What would be the forecasted patient pool (2024-2034) across the seven major markets?</li>
<li>What are the key factors driving the epidemiological trend of hernia?</li>
<li>What will be the growth rate of patients across the seven major markets?<br />
&nbsp;</li>
</ul>

<p><strong>Hernia: Current Treatment Scenario, Marketed Drugs and Emerging Therapies</strong></p>

<ul>
<li>What are the current marketed drugs and what are their market performance?</li>
<li>What are the key pipeline drugs and how are they expected to perform in the coming years?</li>
<li>How safe are the current marketed drugs and what are their efficacies?</li>
<li>How safe are the late-stage pipeline drugs and what are their efficacies?</li>
<li>What are the current treatment guidelines for hernia drugs across the seven major markets?</li>
<li>Who are the key companies in the market and what are their market shares?</li>
<li>What are the key mergers and acquisitions, licensing activities, collaborations, etc. related to the hernia market?</li>
<li>What are the key regulatory events related to the hernia market?</li>
<li>What is the structure of clinical trial landscape by status related to the hernia market?</li>
<li>What is the structure of clinical trial landscape by phase related to the hernia market?</li>
<li>What is the structure of clinical trial landscape by route of administration related to the hernia market?</li>
</ul>

<h4><strong>市场概览：</strong></h4>

<blockquote>
<p>预计到2034年，七大疝气市场将展现出2.28%的复合年增长率。</p>
</blockquote>

<table align="center" border="1" cellpadding="1" cellspacing="1" dir="ltr" style="width:100%">
<thead>
<tr>
<th scope="col" style="width:70%">
<div style="text-align:left">报告属性</div>
</th>
<th scope="col">
<div style="text-align:left">关键统计数据</div>
</th>
</tr>
</thead>
<tbody>
<tr>
<td>
<div><strong>基准年</strong></div>
</td>
<td>
<div>2023</div>
</td>
</tr>
<tr>
<td>
<div><strong>预测年份</strong></div>
</td>
<td>
<div>2024-2034</div>
</td>
</tr>
<tr>
<td>
<div><strong>历史年份</strong></div>
</td>
<td>
<div>2018-2023</div>
</td>
</tr>
<tr>
<td><strong>2024-2034年市场增长率</strong></td>
<td>2.28%</td>
</tr>
</tbody>
</table>

<p style="text-align:justify"><br />
在IMARC集团的最新报告中，对疝气市场进行了全面分析，报告名称为《疝气市场：流行病学、行业趋势、市场份额、规模、增长、机遇和预测 2024-2034》。疝气是指一种医学状况，表现为器官或细胞通过周围肌肉或结缔组织的薄弱部位或开口突出。它最常发生在腹部，但也可能影响身体的其他部位，如股部、横膈膜、脐周等。这种疾病的症状可能因部位和大小而异；然而，通常包括可见的肿块、不适或疼痛、刺痛或灼热感以及沉重感。在某些情况下，疝气可能进展到嵌顿或绞窄状态，此时突出的组织被卡住，导致血液供应受损。该疾病的诊断主要基于患者的病史和典型的临床表现。医疗专业人员还将进行体格检查，以检查受影响区域的可见或可触及的疾病迹象，如肿块或肿胀。推荐进行各种诊断程序，如超声、计算机断层扫描、磁共振成像等，以可视化内部结构并确定潜在病因。</p>

<p style="text-align:center"><img alt="Hernia Market" src="https://www.imarcgroup.com/CKEditor/13da0c78-8086-4f92-9bac-90ba85b37275hernia-market.webp" style="height:450px; width:800px" /></p>

<p style="text-align:justify">先天性综合征病例的增加，这些综合征削弱了腹壁或结缔组织，从而使器官或组织突出，这是推动疝气市场的主要因素。除此之外，各种风险因素（如损伤、重物提举或拉扯、肥胖等）的普遍存在，这些因素会对胃部肌肉施加压力，也为市场的发展提供了积极的展望。此外，有效药物（包括非甾体抗炎药、质子泵抑制剂、轻微缓泻剂等）的广泛应用，以减少胃酸的产生并管理疾病的症状，进一步推动了市场增长。除此之外，物理治疗的应用日益广泛，因为它有助于增强肌肉张力耐力，从而有助于患者更顺利地康复，这也是另一个重要的增长因素。此外，由于机器人辅助手术的诸多优势，如改善可视化、增加活动范围、缩短住院时间等，其在治疗疾病方面的日益流行预计将在预测期内推动疝气市场的发展。</p>

<p style="text-align:justify">IMARC集团的新报告对七大市场（美国、欧盟5国[德国、西班牙、意大利、法国和英国]和日本）的疝气市场进行了详尽的分析。这包括治疗实践、在市和管线药物、个别疗法的市场份额、七大主要市场的市场表现、关键公司的市场表现及其药物等。该报告还提供了七大主要市场的当前和未来患者群体。根据报告，美国拥有最大的疝气患者群体，也是其治疗的最大市场。此外，报告还提供了当前治疗实践/算法、市场驱动因素、挑战、机遇、补偿情景和未满足的医疗需求等信息。本报告对于制造商、投资者、商业策略家、研究人员、顾问以及所有以任何方式对疝气市场有利益或计划进入该市场的人来说都是必读之作。</p>

<p><strong>研究时间范围</strong></p>

<ul>
<li>基准年：2023</li>
<li>历史时期：2018-2023</li>
<li>市场预测：2024-2034<br />
&nbsp;</li>
</ul>

<p><strong>涵盖的国家</strong></p>

<ul>
<li>美国</li>
<li>德国</li>
<li>法国</li>
<li>英国</li>
<li>意大利</li>
<li>西班牙</li>
<li>日本<br />
&nbsp;</li>
</ul>

<p><strong>每个国家覆盖的分析</strong></p>

<ul>
<li>历史、当前和未来的流行病学情景</li>
<li>历史、当前和未来的疝气市场表现</li>
<li>市场内各种治疗类别的历史、当前和未来表现</li>
<li>疝气市场各种药物的销售额</li>
<li>市场补偿情景</li>
<li>在市和管线药物</li>
</ul>

<h4><strong>竞争格局：</strong></h4>

<p>本报告还提供了对当前在市疝气药物和后期管线药物的详细分析。</p>

<p><strong>在市药物</strong></p>

<ul>
<li>药物概述</li>
<li>作用机制</li>
<li>监管状况</li>
<li>临床试验结果</li>
<li>药物采用率和市场表现&nbsp;&nbsp;&nbsp;&nbsp;<br />
&nbsp;</li>
</ul>

<p><strong>后期管线药物</strong></p>

<ul>
<li>药物概述</li>
<li>作用机制</li>
<li>监管状况</li>
<li>临床试验结果</li>
<li>药物采用率和市场表现</li>
</ul>

<h4><strong>本报告解答的关键问题：</strong></h4>

<p><strong>市场洞察</strong></p>

<ul>
<li>疝气市场迄今为止的表现如何，未来几年将如何表现？</li>
<li>2023年各种治疗细分市场的市场份额是多少，预计到2034年将如何表现？</li>
<li>2023年七大主要市场的疝气市场规模是多少，2034年将呈现何种景象？</li>
<li>七大主要市场疝气市场的增长率是多少，未来十年预计将增长多少？</li>
<li>市场中的关键未满足需求是什么？<br />
&nbsp;</li>
</ul>

<p><strong>流行病学洞察</strong></p>

<ul>
<li>七大主要市场疝气的流行病例数（2018-2034）是多少？</li>
<li>七大主要市场按年龄划分的疝气流行病例数（2018-2034）是多少？</li>
<li>七大主要市场按性别划分的疝气流行病例数（2018-2034）是多少？</li>
<li>七大主要市场被诊断为疝气的患者数量（2018-2034）是多少？</li>
<li>七大主要市场的疝气患者群体规模（2018-2023）是多少？</li>
<li>七大主要市场的预测患者群体（2024-2034）将是多少？</li>
<li>推动疝气流行病学趋势的关键因素是什么？</li>
<li>七大主要市场的患者增长率将如何？<br />
&nbsp;</li>
</ul>

<p><strong>疝气：当前治疗情景、在市药物和新兴疗法</strong></p>

<ul>
<li>当前在市药物是什么，它们的市场表现如何？</li>
<li>关键管线药物是什么，预计未来几年将如何表现？</li>
<li>当前在市药物的安全性如何，它们的疗效如何？</li>
<li>后期管线药物的安全性如何，它们的疗效如何？</li>
<li>七大主要市场的疝气药物的治疗指南是什么？</li>
<li>市场中的关键公司是谁，它们的市场份额是多少？</li>
<li>与疝气市场相关的关键合并、许可活动、合作等是什么？</li>
<li>与疝气市场相关的关键监管事件是什么？</li>
<li>与疝气市场相关的临床试验景观结构按状态是什么？</li>
<li>与疝气市场相关的临床试验景观结构按阶段是什么？</li>
<li>与疝气市场相关的临床试验景观结构按给药途径是什么？</li>
</ul>